Abstract
Recreational drug use patterns change constantly, making it imperative that clinicians continuously update their knowledge about current trends of use and abuse. Particularly challenging are substances that have been described as nontraditional, emerging, and Web based, which have increased significantly in the last 2 years. This report reviews the epidemiology, pharmacology, clinical presentation, and toxicity as well as recommended management for 2 classes of emerging substances of abuse: herbal marijuana alternatives (eg, synthetic cannabinoids) and “bath salts” (eg, substituted cathinones). A brief review of the development of the regulation of these substances highlights the challenges associated with surveillance and subsequent enforcement of laws for emerging nontraditional substances of abuse.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
